The need for close monitoring of early psychosis and co-occurring substance misuse

Psychiatrist

Volumn 35, Issue 7, 2011, Pages 241-243

  Caton, Carol L M ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE; CANNABIS; COCAINE; PSYCHEDELIC AGENT; TETRAHYDROCANNABINOL;

BIPOLAR DISORDER; CANNABIS ADDICTION; COMORBIDITY; DISEASE ASSOCIATION; DRUG MISUSE; HUMAN; MENTAL HEALTH CARE; MONITORING; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SUBSTANCE ABUSE;

EID: 79959965163     PISSN: 17583209     EISSN: 17583217     Source Type: Journal    
DOI: 10.1192/pb.bp.110.032342     Document Type: Review

References (43)

1. Phillips P, Johnson S. Drug and alcohol misuse among in-patients with psychotic illnesses in three inner-London psychiatric units. Psychiatr Bull 2003; 27: 217-20. (Pubitemid 36681908)
2. Weaver T, Madden P, Charles V, Stimson G, Renton A, Tyrer P, et al. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Br J Psychiatry 2003; 183: 304-13. (Pubitemid 37243901)
3. VanMastrigt S, Addington J, Addington D. Substance misuse at presentation to an early psychosis program. Soc Psychiatry Psychiatr Epidemiol 2004; 39: 69-72. (Pubitemid 39369110)
4. Barnes TRE, Mutsatsa SH, Hutton SB, Watt HC, Joyce EM. Comorbid substance use and age at onset of schizophrenia. Br J Psychiatry 2006; 188: 237-42. (Pubitemid 43341651)
5. Mauri MC, Vovonteri LS, DeGaspari IF. Substance abuse in first episode schizophrenic patients: a retrospective study. Clin Pract Epidemiol Ment Health 2006; 2: 4-11.
6. Barnett JH, Werners U, Secher SM, Hill KE, Brazil R, Masson K, et al. Substance use in a population-based clinic sample of people with firstepisode psychosis. Br J Psychiatry 2007; 190: 515-20. (Pubitemid 46868836)
7. Wade D, Harrigan S, Edwards J, Burgess PM, Whelan G, McGorry PD. Substance misuse in first-episode psychosis: 15-month prospective follow-up study. Br J Psychiatry 2006; 189: 229-43.
8. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593-602. (Pubitemid 40973434)
9. Volkov ND. Substance use disorders in schizophrenia - clinical implications of comorbidity. Schizophr Bull 2009; 35: 469-72.
10. Caton CLM, Samet S, Hasin DH. When acute-stage psychosis and substance use co-occur: differentiating substance-induced and primary psychotic disorders. J Psychiatr Pract 2000; 6: 256-66.
11. Foti DJ, Kotov R, Guey LT, Bromet EJ. Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. Am J Psychiatry 2010; 167: 987-93.
12. Addington J, Addington D. Effect of substance misuse in early psychosis. Br J Psychiatry 1998; 172 (suppl 33): s134-6.
13. Turkington A, Mulholland CC, Rushe TM, Anderson R, McCaul R, Barrett SL, et al. Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. Br J Psychiatry 2009; 195: 242-8.
14. Schuckit MA. Drug and Alcohol Abuse, 3rd edn. Plenum Publishing, 1989.
15. Satel SL, Edell WS. Cocaine-induced paranoia and psychosis proneness. Am J Psychiatry 1991; 148: 1708-11.
16. McLellan AT, Woody GE, O'Brien CP. Development of psychiatric illness in drug abusers: possible role of drug preference. N Engl J Med 1979; 301: 1310-4. (Pubitemid 10181382)
17. Angrist B. Amphetamine psychosis: clinical variations of a syndrome. In Amphetamine and its Analogs (eds AK Cho, DS Segal): 387-414. Academic Press, 1994.
18. Bowers MB, Swigar ME. Vulnerability to psychosis associated with hallucinogen use. Psychiatry Res 1983; 9: 91-7. (Pubitemid 13026458)
19. D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, et al. The psychotomimetic effect of intravenous delta-9- tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacol 2004; 29: 1558-72. (Pubitemid 38982249)
20. Koskinen J, Lohonen J, Koponen H, Isohanni M, Miettunen J. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr Bull 2010; 36: 1115-30.
21. Minozzi S, Davoli M, Bargagli AM, Amato L, Vecchi S, Perucci CA. An overview of systematic reviews on cannabis and psychosis: discussing apparently conflicting results. Drug Alcohol Rev 2010; 29: 304-17.
22. Arseneault L, Cannon M, Witton J, Murray RM. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 2004; 184: 110-7. (Pubitemid 38186851)
23. Semple DM, McIntosh AM, Lawrie SM. Cannabis as a risk factor for psychosis; systematic review. J Psychopharmacol 2005; 19: 187-94. (Pubitemid 40577224)
24. Henquet C, Murry R, Linszen D, van Os J. The environment and schizophrenia: the role of cannabis use. Schizophr Bull 2005; 31: 608-12. (Pubitemid 41253312)
25. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, BurkeM, et al. Cannabis use and the risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319-28. (Pubitemid 47094993)
26. McGrath J,Welham J, Scott J, Varghese D, Degenhardt L, Hayatbakhsh MR, et al. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry 2010; 67: 440-7.
27. Di Forti M, Morgan C, Dazzan P, Pariante C, Mondelli V, Marques TR, et al. High-potency cannabis and the risk of psychosis. Br J Psychiatry 2009; 195: 448-91.
28. Ley A, Jeffery D, Ruiz J, McLaren S, Gillespie C. Underdetection of comorbid drug use at acute psychiatric admission. Psychiatr Bull 2002; 26: 248-51. (Pubitemid 34727380)
29. Caton CLM, Hasin DS, Shrout PE, Drake RE, Dominguez B, First MB, et al. Stability of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis. Br J Psychiatry 2007; 190: 105-11.
30. Mathias S, Lubman DI, Hides L. Substance-induced psychosis: a diagnostic conundrum. J Clin Psychiatry 2008; 69: 358-67. (Pubitemid 351549387)
31. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, Text Revision (DSM-IV-TR). APA, 2000.
32. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Version for 2007: Ch. 5, F00-F99. WHO, 2007 (http://apps.who.int/classification/apps/icd/icd10online).
33. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005; 62: 975-83. (Pubitemid 41248376)
34. Crebbin K, Mitford E, Paxton R, Turkington D. First episode drug-induced psychosis: a medium term follow up study reveals a high-risk group. Soc Psychiatry Psychiatr Epidemiol 2009; 44: 710-5.
35. Dawson R, Green AI, Drake RE, Lavori PW, McGlashan TH, Schanzer B. An adaptive treatment strategy paradigm for longitudinal treatment research using substance-induced psychosis as an example. Psychopharmacol Bull 2008; 41: 51-67.
36. Drake RE, Caton CLM, Xie H, Hsu E, Gorroochurn P, Samet S, et al. A prospective 2-year study of emergency department patients with early-phase primary psychosis or substance-induced psychosis. Am J Psychiatry 2011; 31 Mar (doi: 10.1176/appi.ajp.2011.10071051).
37. Schanzer MB, First MB, Dominguez B, Hasin DS, Caton CLM. Diagnosing psychotic disorders in the emergency department in the context of substance use. Psychiatr Serv 2006; 57: 1468-73. (Pubitemid 44671658)
38. Hall W, Degenhardt L. What are the policy implications of the evidence on cannabis and psychosis? Can J Psychiatry 2006; 51: 566-74.
39. Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change. Guilford Press, 2002.
40. National Institute on Drug Abuse. A Cognitive Behavioral-Approach: Treating Cocaine Addiction. NIDA (http://archives.drugabuse.gov/txmanuals/cbt/ cbt3.html).
41. Burns T, Firn M. Assertive Outreach in Mental Health: A Manual for Practitioners. Oxford University Press, 2002.
42. Tyrer P, Weaver T. Desperately seeking solutions: the search for appropriate treatment for comorbid substance misuse and psychosis. Psychiatr Bull 2004; 28: 1-2. (Pubitemid 38075631)
43. Johnson S, Thornicroft G, Afuwape S, Leese M, White IR, Hughes E, et al. Effects of training community staff in interventions for substance misuse in dual diagnosis patients with psychosis (COMO study). Cluster randomised trial. Br J Psychiatry 2007; 191: 451-2. (Pubitemid 350069588)